Literature DB >> 20554003

Stereospecificity of hydroxyl group at C-20 in antiproliferative action of ginsenoside Rh2 on prostate cancer cells.

Jie Liu1, Kuniyoshi Shimizu, Hongshan Yu, Chunzhi Zhang, Fengxie Jin, Ryuichiro Kondo.   

Abstract

Prostate cancer is the fifth most common neoplasm worldwide, and the second most common cancer among men. Ginsenosides, the main component of ginseng, have been known for their medicinal effects such as anti-inflammatory and anti-proliferative activities. In this study, we investigated the inhibitory effects of ginsenosides (ginsenoside 20(R)-Rh2 and ginsenoside 20(S)-Rh2) on prostate cancer cells in vitro. Only ginsenoside 20(S)-Rh2 showed proliferation inhibition on androgen-dependent and -independent prostate cancer cells. These results implied that the stereochemistry of the hydroxyl group at C-20 may play an important role in antitumor activities.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20554003     DOI: 10.1016/j.fitote.2010.05.020

Source DB:  PubMed          Journal:  Fitoterapia        ISSN: 0367-326X            Impact factor:   2.882


  24 in total

1.  Ginsenoside Rh2 inhibits metastasis of glioblastoma multiforme through Akt-regulated MMP13.

Authors:  Ning Guan; Xiaochuan Huo; Zhenxing Zhang; Shoudan Zhang; Junsheng Luo; Wenshi Guo
Journal:  Tumour Biol       Date:  2015-04-03

2.  Red ginseng and 20(S)-Rg3 control testosterone-induced prostate hyperplasia by deregulating androgen receptor signaling.

Authors:  Jung-Soo Bae; Hyoung-Sook Park; Jong-Wan Park; Shan-Hua Li; Yang-Sook Chun
Journal:  J Nat Med       Date:  2011-11-20       Impact factor: 2.343

3.  Skin anti-photoaging properties of ginsenoside Rh2 epimers in UV-B-irradiated human keratinocyte cells.

Authors:  Sun-Joo Oh; Sihyeong Lee; Woo-Yong Choi; Chang-Jin Lim
Journal:  J Biosci       Date:  2014-09       Impact factor: 1.826

4.  Sulfated derivative of 20(S)-ginsenoside Rh2 inhibits inflammatory cytokines through MAPKs and NF-kappa B pathways in LPS-induced RAW264.7 macrophages.

Authors:  Wen-Yan Bi; Ben-Dong Fu; Hai-Qing Shen; Qian Wei; Cui Zhang; Zhou Song; Qian-Qian Qin; Hui-Ping Li; Shuang Lv; Shuai-Cheng Wu; Peng-Fei Yi; Xu-Bin Wei
Journal:  Inflammation       Date:  2012-10       Impact factor: 4.092

5.  Ginsenoside Rh2 inhibits growth of glioblastoma multiforme through mTor.

Authors:  Shaoyi Li; Wenchang Guo; Yun Gao; Yunhui Liu
Journal:  Tumour Biol       Date:  2014-11-28

6.  Inhibition of prostatic cancer growth by ginsenoside Rh2.

Authors:  Qingchuan Zhang; Bin Hong; Songhua Wu; Tianli Niu
Journal:  Tumour Biol       Date:  2014-11-23

7.  EGFR signaling-dependent inhibition of glioblastoma growth by ginsenoside Rh2.

Authors:  Shaoyi Li; Yun Gao; Weining Ma; Wenchang Guo; Gang Zhou; Tianci Cheng; Yunhui Liu
Journal:  Tumour Biol       Date:  2014-02-21

8.  Ginsenoside Rh2 alleviates tumor-associated depression in a mouse model of colorectal carcinoma.

Authors:  Jia Wang; Yueming Chen; Chunxiao Dai; Yushan Shang; Jian Xie
Journal:  Am J Transl Res       Date:  2016-05-15       Impact factor: 4.060

9.  Ginsenoside Rh2 inhibits invasiveness of glioblastoma through modulation of VEGF-A.

Authors:  Shaoyi Li; Yun Gao; Weining Ma; Tianci Cheng; Yunhui Liu
Journal:  Tumour Biol       Date:  2015-07-29

10.  Stereoselective regulations of P-glycoprotein by ginsenoside Rh2 epimers and the potential mechanisms from the view of pharmacokinetics.

Authors:  Jingwei Zhang; Fang Zhou; Fang Niu; Meng Lu; Xiaolan Wu; Jianguo Sun; Guangji Wang
Journal:  PLoS One       Date:  2012-04-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.